跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clavsin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clavsin
Approved
STANDARD
Clavsin
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
887d2f4a21c1ade9
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
887d2f4a21c1ade9
Drug Approval Philippines Name
Clavsin
Product Name
Clavsin
Registration Number
DRP-293-01
Brand Name
Clavsin
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Suspension
Dosage Strength
125mg/ 31.25mg per 5mL
Manufacturer
Lloyd Laboratories, Inc.
Distributor
Foramen Products Corporation
Issuance Date
28 October 2021
Expiry Date
12 September 2026
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
887d2f4a21c1ade9
Type
Standard
Back to Philippines FDA Approvals